Individual responses vary
SURMOUNT-1 results (72 weeks, adults with obesity): 5 mg dose: approximately 15% body weight loss 10 mg dose: 19.5% body weight loss 15 mg dose: 22.5% body weight loss Placebo: 3.1% body weight loss At the 15 mg maximum dose, the average participant lost about 52 pounds over 72 weeks
They tout improved insulin sensitivity, nodding to the drug's original purpose, which is to help control blood sugar for patients with type 2 diabetes
So, the question really isnt about which peptide is more effective, rather which one best suits your body, age, and lifestyle
A.Castellano-MartinezA.Cascales-PoyatosH
For personalized guidance on Semaglutide treatment, schedule a consultation with a licensed professional today